Royal Bank of Canada’s Sophiris Bio, Inc. SPHS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-2,079
| Closed | -$1K | – | 7371 |
|
|
2019
Q4 | $1K | Buy |
2,079
+1,000
| +93% | +$454 | ﹤0.01% | 6760 |
|
|
2019
Q3 | $1K | Hold |
1,079
| – | – | ﹤0.01% | 6627 |
|
|
2019
Q2 | $1K | Sell |
1,079
-1,599
| -60% | -$1.4K | ﹤0.01% | 6808 |
|
|
2019
Q1 | $3K | Sell |
2,678
-2,307
| -46% | -$2.48K | ﹤0.01% | 6487 |
|
|
2018
Q4 | $4K | Sell |
4,985
-4,158
| -45% | -$8.18K | ﹤0.01% | 6299 |
|
|
2018
Q3 | $25K | Buy |
9,143
+2,664
| +41% | +$7.58K | ﹤0.01% | 5574 |
|
|
2018
Q2 | $19K | Sell |
6,479
-192
| -3% | -$570 | ﹤0.01% | 5574 |
|
|
2018
Q1 | $13K | Buy |
6,671
+186
| +3% | +$403 | ﹤0.01% | 5641 |
|
|
2017
Q4 | $15K | Sell |
6,485
-326
| -5% | -$710 | ﹤0.01% | 5727 |
|
|
2017
Q3 | $15K | Buy |
6,811
+6
| +0.1% | +$12 | ﹤0.01% | 6128 |
|
|
2017
Q2 | $15K | Sell |
6,805
-77
| -1% | -$189 | ﹤0.01% | 5670 |
|
|
2017
Q1 | $20K | Buy |
6,882
+961
| +16% | +$2.63K | ﹤0.01% | 5638 |
|
|
2016
Q4 | $17K | Sell |
5,921
-146
| -2% | -$413 | ﹤0.01% | 5872 |
|
|
2016
Q3 | $19K | Buy |
6,067
+96
| +2% | +$361 | ﹤0.01% | 5583 |
|
|
2016
Q2 | $13K | Hold |
5,971
| – | – | ﹤0.01% | 5676 |
|
|
2016
Q1 | $9K | Buy |
5,971
+4,473
| +299% | +$7.89K | ﹤0.01% | 5782 |
|
|
2015
Q4 | $2K | Sell |
1,498
-8,354
| -85% | -$12.4K | ﹤0.01% | 6425 |
|
|
2015
Q3 | $8K | Buy |
9,852
+192
| +2% | +$167 | ﹤0.01% | 6024 |
|
|
2015
Q2 | $8K | Hold |
9,660
| – | – | ﹤0.01% | 6161 |
|
|
2015
Q1 | $6K | Buy |
9,660
+326
| +3% | +$174 | ﹤0.01% | 5727 |
|
|
2014
Q4 | $5K | Buy |
9,334
+8,500
| +1,019% | +$19.7K | ﹤0.01% | 5829 |
|
|
2014
Q3 | $2K | Buy |
834
+96
| +13% | +$270 | ﹤0.01% | 5842 |
|
|
2014
Q2 | $2K | Hold |
738
| – | – | ﹤0.01% | 5783 |
|
|
2014
Q1 | $2K | Buy |
738
+96
| +15% | +$376 | ﹤0.01% | 5780 |
|
|
2013
Q4 | $2K | Hold |
642
| – | – | ﹤0.01% | 5803 |
|
|
2013
Q3 | $3K | Buy |
+642
| New | +$2.96K | ﹤0.01% | 5832 |
|
Other funds holding SPHS
Royal Bank of Canada's SPHS Position: Q1 2020 in Review
Royal Bank of Canada sold out of Sophiris Bio, Inc. (SPHS) in Q1 2020, closing a stake of 2,079 shares — an estimated $1K sold.
Royal Bank of Canada first reported a position in SPHS in Q3 2013 and held it in 26 quarters. The position peaked at $25K in Q3 2018. 3 funds tracked by Wall St. Rank hold SPHS as of Q1 2020.
- Royal Bank of Canada reported no remaining Sophiris Bio, Inc. position as of Q1 2020 after selling out during the quarter.
- Royal Bank of Canada sold 2,079 Sophiris Bio, Inc. shares in Q1 2020, an estimated $1K.
- Royal Bank of Canada first reported a position in Sophiris Bio, Inc. in Q3 2013 and held it in 26 quarters.
- Royal Bank of Canada's Sophiris Bio, Inc. position peaked at $25K in Q3 2018.
- 3 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q1 2020.
Based on Royal Bank of Canada's 13F filing for Q1 2020, filed 15 May 2020.